Evidence map›Paper›PMID 36899008›Full record

ArticleCell death & disease2023

Protein dynamics at invadopodia control invasion-migration transitions in melanoma cells.

Marlène Legrand, Antoine Mousson, Philippe Carl, Léa Rossé, Hélène Justiniano, Jean-Pierre Gies, Daniel Bouvard, Emilie Sick, Denis Dujardin, Philippe Rondé

Open access · goldFull text read
In one paragraph

Article in Cell death & disease, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
2.3field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Marlène LegrandCNRS UMR7021, Migration, Invasion and Microenvironnement, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
Antoine MoussonCNRS UMR7021, Migration, Invasion and Microenvironnement, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
Philippe CarlCNRS UMR7021, Migration, Invasion and Microenvironnement, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
Léa RosséCNRS UMR7021, Migration, Invasion and Microenvironnement, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
Hélène JustinianoCNRS UMR7021, Migration, Invasion and Microenvironnement, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
Jean-Pierre GiesCNRS UMR7021, Migration, Invasion and Microenvironnement, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
Daniel BouvardCNRS UMR 5237, Centre de Recherche en Biologie Cellulaire de Montpellier (CRBM), Université de Montpellier, Montpellier, France.
Emilie SickCNRS UMR7021, Migration, Invasion and Microenvironnement, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
Denis DujardinCNRS UMR7021, Migration, Invasion and Microenvironnement, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France.
Philippe RondéCNRS UMR7021, Migration, Invasion and Microenvironnement, Faculté de Pharmacie, Université de Strasbourg, Illkirch, France. philippe.ronde@unistra.fr.ORCID 0000-0001-8740-1824
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cell invasion is a highly complex process that requires the coordination of cell migration and degradation of the extracellular matrix. In melanoma cells, as in many highly invasive cancer cell types these processes are driven by the regulated formation of adhesives structures such as focal adhesions and invasive structures like invadopodia. Structurally, focal adhesion and invadopodia are quite distinct, yet they share many protein constituents. However, quantitative understanding of the interaction of invadopodia with focal adhesion is lacking, and how invadopodia turn-over is associated with invasion-migration transition cycles remains unknown. In this study, we investigated the role of Pyk2, cortactin and Tks5 in invadopodia turnover and their relation with focal adhesions. We found that active Pyk2 and cortactin are localised at both focal adhesions and invadopodia. At invadopodia, localisation of active Pyk2 is correlated with ECM degradation. During invadopodia disassembly, Pyk2 and cortactin but not Tks5 are often relocated at nearby nascent adhesions. We also show that during ECM degradation, cell migration is reduced which is likely related to the sharing of common molecules within the two structures. Finally, we found that the dual FAK/Pyk2 inhibitor PF-431396 inhibits both focal adhesion and invadopodia activities thereby reducing both migration and ECM degradation.

Indexed as

MelanomaPodosomesCell Line, TumorCortactinExtracellular MatrixFocal Adhesion Kinase 2HumansNeoplasm InvasivenessCortactinFocal Adhesion Kinase 2

Identifiers

PMID36899008
PMCPMC10006204
OpenAlexW4323920825

What OpenQuestion holds

Textfull text, public
LicenceCC BY
reference markers read1
measurements read44
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.